May 15th 2025
Six winners and two honorable mentions were revealed at ISPE’s Europe Annual Conference in London.
The evolution of therapeutic modalities drives the adoption of single-use technologies.
ADC Bio to Develop New Bioconjugation Process
February 13th 2018Unlike current approaches where bioconjugation is typically done following the manufacture of the monoclonal antibody and the cytotoxic drug, the new method begins with the antibody supernatants and eliminates the need for extensive chromatographic purification.